FDA Inspection 1005231 — Annamaria De Pellegrin
The FDA completed an inspection of Annamaria De Pellegrin on Mar 10, 2017 in Vittorio Veneto. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 10, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vittorio Veneto (Italy)
Additional details
Clinical Investigator (CI)